CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45high CD11b+ monocytes and enhanced Theiler's murine encephalomyelitis virus-induced demyelinating disease

Journal of NeuroVirology

Volumn 9, Issue 6, 2003, Pages 623-636

  Bennett, Jami L ^a   Elhofy, Adam ^a   Dal Canto, Mauro C ^a   Tani, Mari ^b   Ransohoff, Richard M ^b   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemokines; Chemotaxis; CNS inflammation; Monocyte recruitment; Multiple sclerosis; Neuroinflammation

Indexed keywords

BETA CHEMOKINE; CD11B ANTIGEN; CD45 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; CD69 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERMES ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; L SELECTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOLOGY; INFLAMMATORY INFILTRATE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MACROPHAGE; MALE; MONOCYTE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSGENE; ANIMAL CELL; ANIMAL TISSUE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS TISSUE; CLINICAL FEATURE; CYTOKINE RESPONSE; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; LYMPHOID ORGAN; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MRNA EXPRESSION LEVEL; PERIVASCULAR SPACE; PROTEIN EXPRESSION; THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; TRANSGENIC MOUSE; VIRUS LOAD;

ANIMALIA; ESCHERICHIA COLI; MURINAE; MUS MUSCULUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 0347407828     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/714044484     Document Type: Article

References (51)

1. Aubert C, Brahic M (1995). Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J Virol 69: 3197-3200.
2. Baggiolini M (1998). Chemokines and leukocyte traffic. Nature 392: 565-568.
3. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF (1996). Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol 156: 3017-3023.
4. Boring L, Gosling J, Monteclaro FS, Lusis AJ, Tsou CL, Charo IF (1996). Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein la receptors - evidence for two closely linked C-C chemokine receptors on chromosome 9. J Biol Chem 271: 7551-7558.
5. Brautigam AR, Dutko FJ, Olding LB, Oldstone MB (1979). Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol 44: 349-359.
6. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994). GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14: 1030-1037.
7. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T (1999). Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A 96: 6896-6901.
8. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994). Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91: 3652-3656.
9. Chen BP, Kuziel WA, Lane TE (2001). Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol 167: 4585-4592.
10. Clatch RJ, Lipton HL, Miller SD (1986). Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol 136: 920-927.
11. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL (1990). Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176: 244-254.
12. Cochran BH, Reffel AC, Stiles CD (1983). Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939-947.
13. Dal Canto MC, Lipton HL (1975). Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest 33: 626-637.
14. DeGrendele HC, Kosfiszer M, Estess P, Siegelman MH (1997). CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 159: 2549-2553.
15. Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ (2000). CC Chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med 192: 899-906.
16. Fife BT, Paniagua MC, Lukacs NW, Kunkel SL, Karpus WJ (2001). Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J Neurosci Res 66: 705-714.
17. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA (1995). Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein- 1. J Immunol 155: 5769-5776.
18. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM (1997). Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150: 617-630.
19. Glabinski AR, Tuohy VK, Ransohoff RM (1998). Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5: 166-171.
20. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ (2000). Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
21. Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ (1999). Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J NeuroVirol 5: 635-642.
22. Huang D, Tani M, Wang J, Han Y, He TT, Weaver J, Charo IF, Tuohy VK, Rollins BJ, Ransohoff RM (2002). Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J Neurosci 22: 10633-10642.
23. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM (2001). Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193: 713-726.
24. Karpus WJ, Kennedy KJ (1997). MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62: 681-687.
25. Karpus WJ, Kennedy KJ, Kunkel SL, Lukacs NW (1998). Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med 187: 733-741.
26. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA (1997). Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158: 4129-4136.
27. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995). An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155: 5003-5010.
28. Kennedy KJ, Strieter RM, Kunkel SL, Lukacs NW, Karpus WJ (1998). Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J Neuroimmunol 92: 98-108.
29. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ (1998). Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970-978.
30. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ (2000). A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74: 1415-1424.
31. Liang M, Mallari C, Rosser M, Ng HP, May K, Monahan S, Bauman JG, Islam I, Ghannam A, Buckman B, Shaw K, Wei GP, Xu W, Zhao Z, Ho E, Shen J, Oanh H, Subramanyam B, Vergona R, Taub D, Dunning L, Harvey S, Snider RM, Hesselgesser J, Morrissey MM, Perez HD (2000). Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem 275: 19000-19008.
32. Lipton HL (1975). Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147-1155.
33. Lipton HL, Twaddle G, Jelachich ML (1995). The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 69: 2525-2533.
34. Liu MT, Armstrong D, Hamilton TA, Lane TE (2001). Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 166: 1790-1795.
35. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE (2000). The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165: 2327-2330.
36. Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM, Kunkel SL (1997). C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150: 1861-1868.
37. Lyons CR, Orloff GJ, Cunningham JM (1992). Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370-6374.
38. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ (1989). Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169: 1485-1490.
39. Miller SD, Karpus WJ (1994). The immunopathogenesis and regulation of T-cellmediated demyelinating diseases. Immunol Today 15: 356-361.
40. Miller SD, Karpus WJ, Pope JG, Dal Canto MC, Melvold RW (1994). Theiler's virus-induced demyelinating disease. In Autoimmune disease models, a guidebook. Cohen IR, Miller A (eds). New York: Academic Press, pp 23-38.
41. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA (2000). International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145-176.
42. Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M (2000). Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. J Neuro-Virol 6(Suppl 1): S44-S52.
43. Ozden S, Aubert C, Gonzalez-Dunia D, Brahic M (1991). In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J Histochem Cytochem 39: 1305-1309.
44. Rollins BJ (1997). Chemokines. Blood 90: 909-928.
45. Shinmura Y, Aiba-Masago S, Kosugi I, Li RY, Baba S, Tsutsui (1997). Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Y. Am J Pathol 151: 1331-1340.
46. Theil DJ, Tsunoda I, Libbey JE, Derfuss TJ, Fujinami RS (2000). Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol 104: 22-30.
47. Tsutsui Y, Kashiwai A, Kawamura N, Nagahama M, Mizutani A, Naruse I (1989). Susceptibility of brain cells to murine cytomegalovirus infection in the developing mouse brain. Acta Neuropathol (Berl) 79: 262-270.
48. van Den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ (1999). Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci 19: 10948-10965.
49. Viret C, He X, Janeway CA Jr (2000). On the self-referential nature of naïve MHC class II-restricted T cells. J Immunol 165: 6183-6192.
50. Yamada M, Zurbriggen A, Fujinami RS (1990). The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol 137: 1467-1479.
51. Zlotnik A, Yoshie O (2000). Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.